로딩 중…
지수 로딩 중…
Travere Therapeutics, Inc.
TVTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$55.05+1.68%
2026-06-18
Price Chart
Travere Therapeutics, Inc.+282.03%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.12B |
| Revenue | $536M |
| Net Income | $-21M |
| Total Assets | $555M |
| Net Assets | $99M |
| Value | |
| P/B | 51.85x |
| P/S | 9.55x |
| EV/EBITDA | 148.94x |
| FCF Yield | 0.34% |
| Profitability | |
| ROE | -21.70% |
| ROA | -3.86% |
| Op. Margin | -10.64% |
| Revenue Growth | 55.63% |
| Financial Health | |
| Debt Ratio | 462.34% |
| Total Debt | $328M |
| FCF | $17M |
| Cash | $78M |
| Current Ratio | 3.13x |
| Net Debt/EBITDA | 6.92x |
| Performance | |
| 1Y Return | 282.03% |
| 1M Return | 30.27% |
| From 52W High | -1.68% |
| 1Y MDD | -33.49% |
| Trading | |
| Volume | 4,951,165 shares |
| Trading Value | $272M |
| Per Share | |
| EPS | $-0.56 |
| BPS | $1.27 |